Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka
Movement Disorders in Psychiatry

Movement Disorders in Psychiatry

9780197574317
526,50 zł
473,85 zł Zniżka 52,65 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 473,85 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Movement Disorders in Psychiatry examines the complex interface between movement disorders and psychiatry, addressing both specific movement disorders in psychiatry and behavioral syndromes associated with diseases categorized as movement disorders. This volume provides an overview of clinical definitions and pathophysiology of movement disorders and reviews specific movement disorders associated with drugs of abuse and psychotropic medications, including tardivedyskinesia, akathisia, and neuroleptic malignant syndrome. Further chapters discuss movement disorders seen in primary psychiatric disorders, such as autism and schizophrenia, as well as diseases with concurrent movement disorder and behavioral symptoms, such as Huntingtons disease, Parkinsons disease, frontotemporaldementia, Tourettes syndrome, and autoimmune conditions. Movement Disorders in Psychiatry offers an in-depth perspective on movement disorders with treatment and practical management strategies for related challenges in clinical practice.
Szczegóły produktu
OUP USA
98743
9780197574317
9780197574317

Opis

Rok wydania
2023
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
448
Wymiary (mm)
178 x 254
Waga (g)
790
  • Table of Contents; Preface; Part I: Movement Disorders Overview ; Chapter 1: Introduction to the Movement Disorders: Definition and Clinical Phenotypes; Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo; Chapter 2: Pathophysiology of Primary and Secondary Movement Disorders; Claudio Da Cunha, William Sanchez-Luna, Fernando Henrique Teixeira Zonzini, Daniel R. Benke, and Jose Augusto Pochapski; Part II: Movement Disorders Associated with Psychotropics ; Chapter 3: Dopamine Antagonist-Induced Parkinsonism; Abdulmunaim M. Eid and William G. Ondo; Chapter 4: Akathisia; Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L. Teixeira; Chapter 5: Tardive Dyskinesia; Vinicius Sousa Pietra Pedroso, Jo?o Vinicius Salgado, and Antonio L. Teixeira; Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome; Haitham Salem, Brittany Finocchio, and Teresa Pigott; Chapter 7: Movement Disorders Associated with SSRIs; Jennifer G. Goldman and Carlos Manuel Guerra Galicia; Chapter 8: The Under Recognized Movement Disorders Associated with Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine; Melody Badii and William G. Ondo; Chapter 9: Movement Disorders Associated with Stimulants and Other Drugs of Abuse; Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario Manto; Part III: Movement Disorders Seen in Primary Psychiatric Disorders ; Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum Disorders; Johannes Schröder and Christina J. Herold; Chapter 11: Stereotypies in Childhood Developmental Disorders and Neurodegenerative Diseases; Joohi Jimenez-Shahed; Chapter 12: Catatonia and Hypokinetic Movement Disorders; Nidaullah Mian, Carla Bejjani, and Raja Mehanna; Chapter 13: Functional Movement Disorders; Jennifer S. Sharma and Alberto J. Espay; Part IV: Diseases with Concurrent Psychiatric and Movement Disorders Symptoms ; Chapter 14: Tics and Tourette Syndrome; Abhishek Lenka and Joseph Jankovic; Chapter 15: Huntingtons Disease; Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin Furr-Stimming; Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic Causes of Chorea; Ricardo Maciel, Debora Palma Maia, and Francisco Cardoso; Chapter 17: Parkinsons Disease and Atypical Parkinsonian Syndromes; Julia Ridgeway-Diaz and Laura Marsh; Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing Features, Genetics, Pathology, and Associated Movement Disorders; Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz; Chapter 19: Restless Legs Syndrome and Psychiatric Issues; Emmanuel H. During and John W. Winkelman; Chapter 20: Neurometabolic Diseases; Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig; Chapter 21: Autoimmune and Paraneoplastic Encephalopathies; James F. Rini, Bradley T. Peet, and Michael D. Geschwind;
Komentarze (0)